⚡ Quick Answer
What is the talcum powder lawsuit? Johnson & Johnson's Baby Powder and Shower to Shower were among the most trusted household products for decades — but internal documents show J&J knew its talc was contaminated with asbestos as far back as the 1970s and concealed this from consumers and regulators. Tens of thousands of women who used the products developed ovarian cancer. Workers and long-term users developed mesothelioma. Over 67,000 lawsuits are now pending in federal MDL-2738 in New Jersey. Three attempts by J&J to escape liability through bankruptcy have been rejected by courts. Trials are producing historic verdicts — $1.56 billion in Baltimore in December 2025, $966 million in California in October 2025 (reduced to $16M after punitive damages were struck), and $65.5 million in Minnesota. Attorneys are currently accepting new clients diagnosed on or after January 1, 2016.
Who Qualifies for a Talcum Powder Lawsuit
Eligibility requires a history of regular talcum powder use — including Johnson's Baby Powder, Shower to Shower, or other talc-based body and hygiene products — followed by a qualifying cancer diagnosis. Both prescription and over-the-counter personal care use qualify. Genital application (women) and inhalation during regular use are the two primary exposure routes.
Qualifying Criteria:
Family members of deceased victims may also bring wrongful death claims. Diagnoses as far back as 2016 may qualify depending on date of death and state-specific wrongful death SOL rules.
How Talcum Powder Causes Cancer — What J&J Is Accused Of
Lawsuits allege that Johnson & Johnson knew for decades that its talc products were contaminated with asbestos — and chose to conceal that risk from consumers, regulators, and the public to protect a product it internally referred to as a "sacred cow."
1. Talc Is Naturally Found Near Asbestos — and J&J Knew It
Talc and asbestos deposits form in close proximity underground. During mining and processing, asbestos fibers routinely contaminate talc. Unlike contamination in other drug recalls, which are caused by manufacturing errors, talc's asbestos risk is inherent to where and how it is mined. A 2018 Reuters investigation uncovered internal J&J documents showing the company had knowledge of asbestos in its talc as early as 1957. Internal testing from the 1970s found asbestos in talc samples — at levels described in one report as "rather high" — but those results were never disclosed to the FDA.
2. Decades of Concealment — Internal Documents Are Damaging
Court-produced internal documents — now widely referred to as the "J&J Papers" — show that company executives discussed the asbestos contamination problem in private memos while publicly insisting the products were safe. The company had access to a cornstarch-based alternative as early as the 1970s but chose not to switch, citing cost and market considerations. Juries have awarded punitive damages specifically because of this pattern of knowing concealment. The $1.56 billion Baltimore verdict and the original $966 million California verdict both reflected jury findings of deliberate misconduct.
3. Failure to Warn Consumers
No Johnson & Johnson talc product ever carried a cancer warning. Plaintiffs allege J&J had internal evidence of contamination for decades but actively marketed the products as pure, safe, and gentle — including for use on infants. The FDA began requiring asbestos testing of cosmetic talc in 1973, but internal documents show contamination was found in testing and not disclosed to regulators. In March 2026, The Lancet retracted a 1977 commentary on talc safety after it was revealed the author was an undisclosed paid consultant of J&J who shared drafts with the company before publication — removing a key piece of J&J's defense.
4. The "Texas Two-Step" Bankruptcy — Three Failed Attempts
Rather than face liability in open court, J&J attempted three times to use a controversial maneuver called the "Texas Two-Step": creating a subsidiary (first LTL Management, then Red River Talc LLC, then Pecos River Talc LLC), transferring talc liabilities to it, and having the subsidiary file for bankruptcy to cap the company's total exposure. All three attempts were rejected by federal judges as "bad faith" manipulation of the bankruptcy system — with courts finding that J&J, worth nearly $500 billion, was not in financial distress. The litigation is now proceeding in earnest for the first time in years.
Cancers Covered in Active Talcum Powder Claims
The federal MDL and state court programs cover two distinct cancer categories: asbestos-related cancers (primarily mesothelioma — the basis for most major verdicts) and ovarian/gynecological cancers from genital talc application (the basis for most of the 67,000+ MDL cases). Each category has different scientific evidence and different typical case values.
Asbestos-Related — Highest Verdict Values
Gynecological — Majority of MDL Cases
Verdict History & Settlement Value Factors
Recent jury verdicts have been historic. The $1.56 billion Baltimore verdict in December 2025 is the largest single-plaintiff talc award ever recorded. Ovarian cancer cases have also produced meaningful awards. Settlement estimates for individual claims vary widely by cancer type and case facts.
Recent Notable Verdicts:
- 🔴
$1.56 billion — Baltimore, December 2025. Cherie Craft, peritoneal mesothelioma. Largest single-plaintiff talc award. J&J plans to appeal.
- 🔴
$966 million — California, October 2025. Reduced to $16M after judge struck punitive damages; family appealing. Compensatory damages upheld.
- 🔴
$65.5 million — Minnesota, December 2025. Pleural mesothelioma.
- 🔴
$42.6 million — Massachusetts, August 2025. Mesothelioma.
- 🔴
$40 million — California, December 2025. Two ovarian cancer plaintiffs.
- 🔴
$250,000 — Philadelphia, February 2026. Ovarian cancer wrongful death; first Philadelphia mass tort bellwether result.
- 🔴
$20 million — Florida, November 2025. Mesothelioma.
Factors That Affect Individual Case Value:
- 🔴
Cancer type — Mesothelioma cases command significantly higher values due to the direct asbestos link and severe prognosis. Ovarian cancer cases are more numerous but typically lower in individual value.
- 📅
Duration and frequency of use — Daily use over many years or decades is the strongest exposure profile. Receipts, family testimony, or loyalty card purchase history can help establish use.
- 🩺
Severity of illness and prognosis — Active cancer, treatment history, recurrence, and long-term health impact all factor into damages.
- 💼
Medical expenses and lost income — Chemotherapy, surgery, ongoing treatment, lost wages, and diminished earning capacity all contribute to compensatory damages.
- ⚖️
Punitive damages availability — J&J's pattern of concealment supports punitive damage claims, though courts and appellate panels have reduced punitive awards post-trial in some cases.
Based on legal analyst estimates and Mealey's Litigation Reports data:
Mesothelioma — strong product ID: $1M – $8M+ (mesothelioma cases have historically resolved higher)
Ovarian cancer — long-term daily use, 2016+ diagnosis: $300,000 – $1M+
Wrongful death (mesothelioma or ovarian cancer): Varies widely by state law and facts
These are analyst estimates only and do not represent a guarantee of any outcome. Compensation depends entirely on case-specific facts.
Disclaimer: Past verdicts and settlements do not guarantee future outcomes. Case value depends on individual circumstances, cancer type, evidence, venue, and litigation developments.
Filing Deadlines by State
Every state has strict statutes of limitations for product liability claims — typically 2–3 years from the date of cancer diagnosis or from when you reasonably could have known that talc caused your cancer. Many states apply a discovery rule that may extend your window. Missing your deadline permanently bars your claim.
| State | Personal Injury SOL | Wrongful Death SOL | Notes |
|---|---|---|---|
| New Jersey | 2 years | 2 years | Federal MDL-2738 located here; most active talc venue in the country |
| California | 2 years | 2 years | Active JCCP state court program in LA; multiple major verdicts including $966M (reduced) |
| Pennsylvania | 2 years | 2 years | Philadelphia mass tort program established June 2025; bellwether trial produced $250K ovarian cancer verdict (Feb. 2026) |
| New York | 3 years | 2 years | Longer personal injury SOL provides more flexibility; individual cases active |
| Florida | 2 years | 2 years | $20M verdict in Broward County (Nov. 2025); active Broward and Dade county dockets |
| Illinois | 2 years | 2 years | $45M mesothelioma verdict (Chicago, 2024); active Cook County docket |
| Texas | 2 years | 2 years | Active filings; J&J's bankruptcy attempts were filed in Texas federal court before being rejected |
| Maryland | 3 years | 3 years | Site of record-breaking $1.56B verdict (Dec. 2025); Baltimore City active venue |
| All Other States | Typically 2–3 years | Typically 1–3 years | Active cases filed in all 50 states. Do not assume it is too late — consult an attorney immediately. |
Talcum Powder Lawsuit Updates — 2026
Last updated June 2026. We update this section monthly with MDL activity, trial results, and settlement news.
-
April 27, 2026 LatestCourt-Ordered MDL Mediation Rescheduled to April 27: The court-ordered mediation session for the talcum powder MDL was rescheduled from April 13 to April 27, 2026. The first mediation session was held September 4, 2025, with both sides required to participate in good faith under the supervision of court-appointed mediator Fouad Kurdi. These sessions are the primary vehicle for any potential global ovarian cancer settlement.
-
March 31, 2026The Lancet Retracts 1977 Talc Safety Commentary: The Lancet retracted a 1977 commentary titled "Cosmetic Talcum Powder" after disclosing that the author was an undisclosed paid consultant to Johnson & Johnson who shared drafts with the company before publication. The piece had been used for decades by J&J's legal and scientific teams to defend the safety of talc — its retraction removes a significant pillar of J&J's defense in ongoing cases.
-
March 18, 2026California Judge Strikes $950M Punitive Award in Mae Moore Case: A Los Angeles judge overturned the punitive damages portion of the October 2025 $966 million California verdict, reducing the award to $16 million in compensatory damages. The judge found the evidence did not meet the legal standard for punitive damages. The Moore family's attorneys announced plans to appeal. J&J is separately appealing the $16M compensatory award. The jury's underlying finding — that J&J's talc caused Moore's mesothelioma — remains intact.
-
February 19, 2026Philadelphia Bellwether: $250,000 Ovarian Cancer Verdict: A Philadelphia jury awarded $250,000 — including punitive damages — to the family of a woman who died from ovarian cancer after using J&J baby powder. This is the first verdict from the Philadelphia mass tort program established in June 2025 and will help calibrate settlement ranges for the 26+ cases currently pending in that court.
-
January 27, 2026Federal Judge Issues Landmark 685-Page Ruling on Ovarian Cancer Expert Testimony: U.S. District Judge Freda Wilson issued a 685-page ruling confirming that plaintiff experts used "reliable methodologies" to establish the link between talcum powder and ovarian cancer. The ruling allows expert testimony in all 67,000+ MDL cases and represents the most significant win for ovarian cancer plaintiffs since the litigation began.
-
January 9, 2026MDL Grows by 9,375 Cases in a Single Year: Talc MDL-2738 increased by 9,375 cases from the prior year, making it the largest active MDL in the United States with over 67,000 pending claims as of early 2026. New lawsuits continue to be filed despite J&J's efforts to reach a global resolution.
-
December 22, 2025$1.56 Billion Verdict — Largest Single-Plaintiff Talc Award Ever: A Baltimore City jury awarded $1.56 billion to Cherie Craft, a Maryland woman diagnosed with peritoneal mesothelioma after decades of daily use of J&J baby powder. The jury found J&J liable for failing to warn consumers about asbestos contamination. The verdict included compensatory and punitive damages. J&J has announced plans to appeal.
-
December 19, 2025$65.5 Million Minnesota Verdict: A Minnesota jury awarded $65.5 million to a mother of three diagnosed with pleural mesothelioma after the jury found J&J failed to warn consumers about asbestos contamination in baby powder.
-
December 16, 2025$40 Million California Ovarian Cancer Verdict: A California jury awarded $40 million to two women who developed ovarian cancer after decades of using J&J talc products — one of the largest ovarian cancer verdicts in the litigation and a significant data point for settlement valuation of MDL ovarian cancer cases.
-
April 2025J&J's Third Bankruptcy Attempt Rejected — Litigation Resumes: A federal judge rejected J&J's third "Texas Two-Step" bankruptcy attempt, ruling the strategy was a bad-faith manipulation of the bankruptcy system. The court found that J&J — a nearly $500 billion company — was not in genuine financial distress. The ruling ended J&J's years-long effort to avoid individual trials and returned all talc litigation to normal MDL and state court proceedings.
-
July 2024WHO Determines Talc "Probably" Causes Ovarian Cancer: The World Health Organization's International Agency for Research on Cancer (IARC) issued a landmark determination that talc use in the genital area "probably increases the risk of ovarian cancer," directly supporting the scientific basis for the tens of thousands of ovarian cancer claims in MDL-2738.
Diagnosed With Ovarian Cancer or Mesothelioma After Using Talcum Powder?
Attorneys are accepting cases for diagnoses from 2016 forward. J&J's bankruptcy shields have been rejected. Trials are producing the largest verdicts in the litigation's history. Find out if you qualify — free, confidential case review.
Start My Free Case ReviewHow the Talcum Powder Lawsuit Process Works
Talcum powder attorneys work on contingency — you pay nothing unless compensation is recovered.
- Free confidential consultation — Share your talc use history and cancer diagnosis with an attorney at no cost. You do not need pharmacy records or receipts in hand before reaching out. Family testimony and personal recollection of product use are often sufficient to begin the process.
- Case review and evidence gathering — Your attorney documents your history of talc use (product brand, years used, frequency, application method), obtains medical records confirming your cancer diagnosis and treatment, and identifies any purchase records, photos, or family testimony that corroborates product use.
- Confirming your diagnosis falls within the 2016+ window — Attorneys are currently accepting diagnoses from January 1, 2016 forward for both ovarian cancer and mesothelioma. If your diagnosis was before 2016, an attorney can still assess whether a discovery rule argument may preserve your claim.
- Filing the lawsuit — Your case is filed in the federal MDL in New Jersey (MDL-2738), the California JCCP program, the Philadelphia mass tort program, or a state court in your jurisdiction, depending on your circumstances and best venue strategy.
- Discovery — Both sides exchange evidence. Internal J&J documents — including testing records showing asbestos in talc, executive memos discussing the contamination problem, and marketing materials used despite known risk — have been among the most powerful evidence in prior trials.
- Bellwether trials and settlement negotiations — Bellwether trials are ongoing in California, Pennsylvania, and New Jersey. Results from these cases — including the $1.56B Baltimore verdict, the $65.5M Minnesota verdict, and the $40M California ovarian cancer verdict — are shaping settlement expectations for all pending cases. Court-ordered mediation is ongoing.
- Compensation distributed — If your case settles or a jury verdict is reached, your attorney is paid a contingency percentage (typically 33–40%). If they don't recover, you owe nothing.
Frequently Asked Questions
Who qualifies for a talcum powder lawsuit?
You may qualify if you used Johnson's Baby Powder, Shower to Shower, or other talc-based personal care products regularly and were subsequently diagnosed with ovarian cancer, endometrial cancer, peritoneal mesothelioma, or pleural mesothelioma.
Attorneys are currently accepting cases for diagnoses from January 1, 2016 forward. Family members of deceased victims may also bring wrongful death claims. Contact an attorney even if you're unsure — the consultation is free.
What cancers are linked to talcum powder?
Talcum powder containing asbestos is linked to mesothelioma — a rare, aggressive cancer of the lung lining (pleural) or abdominal lining (peritoneal). This cancer is almost exclusively caused by asbestos exposure and has produced the largest verdicts in the litigation.
Regular genital use of talc is linked to ovarian cancer and endometrial cancer. In July 2024, WHO determined that genital talc use "probably increases the risk of ovarian cancer." A January 2026 federal court ruling confirmed the reliability of plaintiff expert testimony establishing this link across 67,000+ MDL cases.
Has J&J settled the talcum powder lawsuits?
No global settlement has been finalized. J&J's proposed $8.9 billion bankruptcy settlement was rejected by courts in April 2025 as a "bad faith" abuse of the bankruptcy system. Courts found J&J — worth nearly $500 billion — was not in genuine financial distress.
Court-ordered mediation is ongoing, with sessions continuing in 2026 under mediator Fouad Kurdi. J&J is not currently offering a mass settlement for ovarian cancer cases. Mesothelioma cases are litigated and sometimes resolved individually. Trials continue to produce massive verdicts.
How much is a talcum powder lawsuit worth?
Mesothelioma verdicts have ranged from $8 million to $1.56 billion. Ovarian cancer verdicts vary; the December 2025 California verdict awarded $40 million to two plaintiffs combined. Settlement estimates based on Mealey's data suggest mesothelioma cases resolve higher on average ($1M–$8M+) and ovarian cancer cases in the $300,000–$1M+ range for strong cases.
Individual case value depends on cancer type and severity, duration of talc use, age at diagnosis, medical expenses, lost income, and availability of punitive damages in your jurisdiction. All amounts depend entirely on case-specific facts.
Did J&J know their talc contained asbestos?
Yes, according to internal documents produced in litigation. A 2018 Reuters investigation found J&J had knowledge of asbestos in its talc as far back as 1957. Internal testing from the 1970s found asbestos at levels described as "rather high" in one report — but those findings were never disclosed to the FDA. In March 2026, The Lancet retracted a 1977 commentary long used in J&J's defense, after disclosing the author was an undisclosed paid J&J consultant who shared drafts with the company before publication. Massive punitive damage awards — including $1.44B in the December 2025 Baltimore verdict — reflect jury findings that J&J's conduct was deliberate and reckless.
Is J&J still selling talcum powder?
No. J&J discontinued talc-based baby powder in the U.S. and Canada in 2020 and globally in 2023, replacing it with cornstarch-based alternatives. However, lawsuits continue for individuals who used the products before discontinuation — cancer from asbestos exposure often has a latency period of 10 to 50 years, meaning people who used the products before 2020 may only now be receiving diagnoses.
What if my loved one died from talc-linked cancer?
Family members of deceased victims may file wrongful death lawsuits. Wrongful death claims typically have shorter statutes of limitations than personal injury claims (1–3 years from date of death depending on state) and are strictly enforced. Recent wrongful death verdicts include $45 million (Chicago, 2024) and components of the $1.56B Baltimore verdict. Contact an attorney immediately to preserve your rights — do not assume it is too late without confirming your state's specific deadline.
What is the difference between the talc MDL and a class action?
The talcum powder litigation is structured as a mass tort (MDL — Multidistrict Litigation), not a class action. In a class action, all plaintiffs share a common resolution. In an MDL, each plaintiff maintains their own individual case with separate damages based on their specific cancer type, exposure history, and circumstances. This is why verdicts range from $250,000 to $1.56 billion — each case is evaluated and valued on its own merits. An attorney represents you individually and advocates for your specific case value.
